Longitudinal Graft Monitoring
Longitudinal Graft Monitoring - Related Videos
11:05
Capillary Electrophoresis to Monitor Peptide Grafting onto Chitosan Films in Real Time
0 Views •
Cited by 1 •
2016
Free solution capillary electrophoresis is a fast, cheap and robust analytical method that enables the quantitative monitoring of chemical reactions in real time. Its utility for rapid, convenient and precise analysis is demonstrated here through analysis of covalent peptide grafting onto chitosan films for improved cell adhesion.
11:17
Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
0 Views •
Cited by 9 •
2015
A step-by-step protocol for the inter-positional placement of Tissue Engineered Vessels (TEVs) into the carotid artery of a sheep using end-to-end anastomosis and real-time digital assessment in vivo until animal sacrifice.
07:02
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
0 Views •
Cited by 34 •
2019
Here, we present a protocol to monitor survival on a single-cell basis and identify variables that significantly predict cell death.
02:20
Longitudinal Research
0 Views •
2020
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
07:51
A Novel Approach to Monitoring Graft Neovascularization in the Human Gingiva
0 Views •
Cited by 7 •
2019
This study introduces a protocol for measuring microcirculation in human oral mucosa by laser speckle contrast imaging. The monitoring of wound healing after vestibuloplasty combined with a xenogenic collagen graft is presented on a clinical case.
FAQs
An established graft baseline gives clinicians a reference for interpreting later findings rather than relying on a single isolated result. Serial changes can show whether graft function is stable, improving, or declining. This trend-based approach may identify clinically important changes earlier and supports decisions about further evaluation, treatment, and ongoing patient care.
Laboratory biomarkers provide repeated measures related to graft function, while imaging can contribute information about structural or vascular problems. Tissue biopsy offers direct examination of graft tissue when it is indicated. Using these assessment types together allows clinicians to compare functional, structural, and tissue-level findings instead of depending on one source alone.
Changes from the established graft baseline may signal rejection, infection, drug toxicity, vascular problems, or gradual graft dysfunction. These conditions can produce different patterns across clinical evaluations, laboratory findings, imaging, and biopsy results. Recognizing the pattern over time helps clinicians investigate the possible cause and determine whether patient management should change.
Serial graft findings provide objective evidence that can help clinicians individualize immunosuppression. A changing pattern may prompt assessment of whether treatment is controlling a complication, whether the graft is responding, or whether drug toxicity could be contributing to dysfunction. This makes medication management responsive to the patient’s observed course rather than to a fixed plan alone.
The workflow begins with repeated clinical evaluations and comparison of current findings with the graft’s established baseline. Laboratory biomarkers and imaging are incorporated to follow function and detect possible complications. When the available findings indicate a need for greater clarification, clinicians may add tissue biopsy, then use the combined results to guide care.
Tissue biopsy is used when clinicians need additional information beyond clinical evaluations, laboratory biomarkers, and imaging. It is not presented as the only monitoring method, but as an assessment performed when indicated. Its findings can help clarify changes in the graft and contribute to evaluating suspected complications or the response to treatment.
Following graft findings over time allows clinicians to compare the patient’s status before and after management changes. The resulting trends can show whether treatment is producing the intended response and provide objective data for ongoing care. In transplant medicine, this information also supports efforts to improve long-term graft survival and patient outcomes.